Table 4.
Treatment | Hb (mg/ml) | P50 (mmHg) | pH | K+ (mmol/L) | Na+ (mmol/L) | ATPase (U/107 cells) | 2,3-DPG (g/L) | Free Hb (mg/ml) |
Control | 62.20±15.87 | 20.28±7.81 | 7.45±0.11 | 1.46±0.56 | 148.28±0.46 | 0.080±0.012 | 9.67±2.09 | 0.089±0.008 |
Cisplatin (μg/ml) | ||||||||
100 | 61.93±15.66 | 25.78±2.88 | 7.42±0.09 | 1.91±0.51 | 149.33±1.23 | 0.069±0.015 | 8.94±2.07 | 0.092±0.008 |
200 | 60.53±14.18 | 27.40±3.59 | 7.29±0.14* | 2.05±0.46 | 150.25±1.14 | 0.061±0.022 | 8.17±2.20 | 0.096±0.008 |
HT30+cisplatin (μg/ml) | ||||||||
0 | 63.55±14.03 | 25.70±3.99 | 7.44±0.14 | 1.74±0.49 | 148.63±0.64 | 0.068±0.032 | 9.09±2.13 | 0.091±0.005 |
100 | 61.73±14.03 | 27.00±3.71 | 7.35±0.16 | 2.12±0.68 | 149.95±1.16 | 0.059±0.023 | 8.01±2.10 | 0.099±0.008* |
200 | 59.65±15.69 | 27.90±3.15 | 7.25±0.12** | 2.29±0.60* | 155.45±1.13* | 0.051±0.015* | 7.71±1.79 | 0.102±0.009** |
Data are expressed as mean±SD, with n=10 in each experiment
P<0.05 vs. control (treated at 37 °C for 30 min)
P<0.01 vs. control (treated at 37 °C for 30 min)